Melinta Therapeutics, Inc. (NASDAQ:MLNT)

7.45
Delayed Data
As of Jun 21
 -0.50 / -6.29%
Today’s Change
5.20
Today|||52-Week Range
24.25
-52.85%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Wechsler Daniel Mark
Director
Buy5/29/201850,000$5.00$250.0K+18.25%
Zaccardelli David
Director
Buy5/29/201840,000$5.00$200.0K+18.25%
Estrem Paul
Chief Financial Officer
Buy5/29/201810,000$5.00$50.0K+18.25%
Gill David Neil
Director
Buy5/25/20185,000$6.09$30.5K+19.20%
Cammarata Sue
Chief Medical Officer
Buy5/29/20184,000$5.00$20.0K+18.25%
Duffy Erin M
Chief Scientific Officer
Buy5/29/20184,000$5.00$20.0K+18.25%